Publication:
Mechanisms of vascular aging: What can we learn from Hutchinson-Gilford progeria syndrome?

dc.contributor.authordel Campo, Lara
dc.contributor.authorHamczyk, Magda R.
dc.contributor.authorAndres, Vicente
dc.contributor.authorMartinez-Gonzalez, Jose
dc.contributor.authorRodriguez, Cristina
dc.contributor.funderMinisterio de Economía, Industria y Competitividad (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderFundación La Marató TV3
dc.contributor.funderProgeria Research Foundation
dc.contributor.funderCentro de Investigación Biomedica en Red - CIBER
dc.contributor.funderFundación ProCNIC
dc.date.accessioned2019-07-19T13:24:46Z
dc.date.available2019-07-19T13:24:46Z
dc.date.issued2018-06
dc.description.abstractAging is the main risk factor for cardiovascular disease (CVD). The increased prevalence of CVD is partly due to the global increase in life expectancy. In this context, it is essential to identify the mechanisms by which aging induces CVD, with the ultimate aim of reducing its incidence. Both atherosclerosis and heart failure significantly contribute to age-associated CVD morbidity and mortality. Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder caused by the synthesis of progerin, which is noted for accelerated aging and CVD. This mutant form of prelamin A induces generalised atherosclerosis, vascular calcification, and cardiac electrophysiological abnormalities, leading to premature aging and death, mainly due to myocardial infarction and stroke. This review discusses the main vascular structural and functional abnormalities during physiological and premature aging, as well as the mechanisms involved in the exacerbated CVD and accelerated aging induced by the accumulation of progerin and prelamin A. Both proteins are expressed in non-HGPS individuals, and physiological aging shares many features of progeria. Research into HGPS could therefore shed light on novel mechanisms involved in the physiological aging of the cardiovascular system.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipEl trabajo desarrollado en el laboratorio de V. A. se ha financiado por el Ministerio de Economía, Industria y Competitividad (MEIC; SAF2016-79490-R) y el Instituto de Salud Carlos III (ISCIII) (RD12/0042/0028 y AC16/00091), con cofinanciación del Fondo Europeo de Desarrollo Regional (FEDER), de la Fundació Marató de TV3 (122/C/2015) y la Progeria Research Fundation (Established Investigator Award 2014-52). El CIBER de Enfermedades Cardiovasculares es una iniciativa del ISCIII. L. C. recibió una ayuda del programa de becas posdoctorales Jordi Soler de la Red de Investigación Cardiovascular (ISCIII) y M. R. H., una ayuda predoctoral del programa FPI del MEIC (BES-2011-043938). El CNIC cuenta con el apoyo del MEIC y de la Fundación Pro-CNIC y ha sido acreditado como Centro de Excelencia Severo Ochoa (MEIC SEV-2015-0505).es_ES
dc.format.number3es_ES
dc.format.page120-132es_ES
dc.format.volume30es_ES
dc.identifier.citationClin Investig Arterioscler. 2018; 30(3):120-32es_ES
dc.identifier.doi10.1016/j.arteri.2017.12.007es_ES
dc.identifier.e-issn1578-1879es_ES
dc.identifier.issn02149168es_ES
dc.identifier.journalClinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosises_ES
dc.identifier.pubmedID29602596es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7967
dc.language.isospaes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2016-79490-Res_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD12/0042/0028es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/BES-2011-043938es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SEV-2015-0505es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.arteri.2017.12.007es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Fisiopatología Cardiovascular Molecular y Genéticaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectAterosclerosises_ES
dc.subjectAtherosclerosises_ES
dc.subjectCalcificación vasculares_ES
dc.subjectCardiovascular diseasees_ES
dc.subjectEnfermedad cardiovasculares_ES
dc.subjectPrelamin A/lamin Aes_ES
dc.subjectPrelamina A/lamina Aes_ES
dc.subjectProgerines_ES
dc.subjectProgerinaes_ES
dc.subjectVascular calcificationes_ES
dc.subject.meshAge Factorses_ES
dc.subject.meshAginges_ES
dc.subject.meshCardiovascular Diseaseses_ES
dc.subject.meshCardiovascular Systemes_ES
dc.subject.meshHumanses_ES
dc.subject.meshLamin Type Aes_ES
dc.subject.meshMyocardial Infarctiones_ES
dc.subject.meshProgeriaes_ES
dc.subject.meshRisk Factorses_ES
dc.subject.meshStrokees_ES
dc.titleMechanisms of vascular aging: What can we learn from Hutchinson-Gilford progeria syndrome?es_ES
dc.typejournal articlees_ES
dc.type.hasVersionAMes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication9449176f-7586-4ca1-b5c3-8a27f0299853
relation.isAuthorOfPublicationf315c565-17c9-4492-a087-f77cddd7fe88
relation.isAuthorOfPublication3bb85851-071a-490a-976b-c234983847a7
relation.isAuthorOfPublication.latestForDiscovery9449176f-7586-4ca1-b5c3-8a27f0299853

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
MechanismsOfVascularAging_2018.pdf
Size:
1.34 MB
Format:
Adobe Portable Document Format
Description: